Louise Kezerle
Overview
Explore the profile of Louise Kezerle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bar-Moshe A, Abu-Salman A, Frumkin E, Cafri C, Merkin M, Bereza S, et al.
Heart Rhythm O2
. 2025 Jan;
5(12):873-882.
PMID: 39803621
Background: Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic stenosis and has become the standard of care across a broad spectrum of patients with aortic stenosis. However,...
2.
Westreich R, Tsaban G, Barrett O, Kezerle L, Tsadok M, Akriv A, et al.
J Thromb Thrombolysis
. 2023 Nov;
57(2):322-329.
PMID: 37945939
Background: Diabetes mellitus (DM) is associated with increased risk of embolic complications in non-valvular atrial fibrillation (NVAF). Impaired renal function (IRF) increases the risk of stroke as well, but this...
3.
Tsaban G, Ostrovsky D, Alnsasra H, Burrack N, Gordon M, Babayev A, et al.
Eur Heart J
. 2023 Nov;
45(5):379-388.
PMID: 37939798
Background And Aims: Amiodarone-related interstitial lung disease (ILD) is the most severe adverse effect of amiodarone treatment. Most data on amiodarone-related ILD are derived from periods when amiodarone was given...
4.
Kezerle L, Haim M, Akriv A, Berliner Senderey A, Bachrach A, Leventer-Roberts M, et al.
Am J Cardiol
. 2022 Apr;
172:48-53.
PMID: 35361475
Diabetes mellitus (DM) is associated with an increased risk of complications in atrial fibrillation (AF). This study aimed to assess the incidence and risks of ischemic stroke and mortality according...
5.
Kezerle L, Tsadok M, Akriv A, Berliner Senderey A, Bachrach A, Leventer-Roberts M, et al.
J Am Coll Cardiol
. 2021 Feb;
77(7):875-884.
PMID: 33602470
Background: Diabetes mellitus (DM) increases the risk of embolism in nonvalvular atrial fibrillation (NVAF). The association between pre-diabetes and risk of ischemic stroke has not been studied separately in this...
6.
Kezerle L, Yohanan E, Cohen A, Merkin M, Ishay Y, Weinstein J, et al.
J Card Surg
. 2020 Aug;
35(10):2719-2724.
PMID: 32743834
Background And Aim: Revascularization guidelines support routine Heart Team (HT) discussion of appropriate patients. The effect of HT on decision making and clinical outcomes has not been explored. The aim...
7.
Kezerle L, Tsadok M, Berliner Senderey A, Hoshen M, Leventer-Roberts M, Reges O, et al.
J Cardiovasc Electrophysiol
. 2020 Mar;
31(6):1356-1363.
PMID: 32212197
Introduction: Oral anticoagulation (OAC) therapy reduces the risk of ischemic stroke in patients with atrial fibrillation (AF) while increasing the risk of bleeding. Recently, non-vitamin K antagonist oral anticoagulants (NOACs)...
8.
Kezerle L, Sagy I, Shalev L, Erez O, Barski L
Rambam Maimonides Med J
. 2018 Mar;
9(2).
PMID: 29514040
Objectives: Peripartum cardiomyopathy (PPCM) is a serious complication of pregnancy. Studies investigating the risk factors that worsen outcomes have yielded conflicting results. The goals of this study were to describe...
9.
Sagy I, Abu Salman A, Kezerle L, Erez O, Yoel I, Barski L
Heart Lung
. 2017 Aug;
46(5):369-374.
PMID: 28779903
Background: Peri-partum cardiomyopathy (PPCM) is a clinical heart failure that usually develops during the final stage of pregnancy or the first months following delivery. High maternal serum uric acid concentrations...
10.
Kezerle L, Shalev L, Barski L
Diabetes Metab Syndr Obes
. 2014 Sep;
7:391-400.
PMID: 25210468
The prevalence of diabetes is rising in the >65 year-old group. The challenge of defining the goals of therapy arises from the heterogeneity of the aging process and the sparse...